Heparin therapy for complications of placental dysfunction: A systematic review of the literature

References

• Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005; 365(9461)785–99
   PubMed Web of Science ®Google Scholar
• Laws PJ, Sullivan EA. Australia's mothers and babies, 2002. Australian Institute of Health and Welfare, National Perinatal Statistics Unit, Sydney 2004
   Google Scholar
• Bernstein IM, Horbar JD, Badger GJ, Ohlsson A, Golan A. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. Am J Obstet Gynecol. 2000; 182: 198–206
   PubMed Web of Science ®Google Scholar
• McIntire DD, Bloom SL, Casey BM, Leveno KJ. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med. 1999; 340: 1234–8
   PubMed Web of Science ®Google Scholar
• Cnattingius S, Haglund B, Kramer MS. Differences in late fetal death rates in association with determinants of small for gestational age fetuses: population based cohort study. BMJ. 1998; 316: 1483–7
   PubMed Web of Science ®Google Scholar
• Kok JH, den Ouden AL, Verloove-Vanhorick SP, Brand R. Outcome of very preterm small for gestational age infants: the first nine years of life. BJOG. 1998; 105: 162–8
   Web of Science ®Google Scholar
• Roth S, Chang TC, Robson S, Spencer JA, Wyatt JS, Stewart AL. The neurodevelopment outcome of term infants with different intrauterine growth characteristics. Early Hum Dev. 1999; 55: 39–50
   PubMed Web of Science ®Google Scholar
• Tan TY, Yeo GS. Intrauterine growth restriction. Curr Opin Obstet Gynecol. 2005; 17: 135–42
   PubMed Web of Science ®Google Scholar
• Khong TY. Placental vascular development and neonatal outcome. Semin Neonatol. 2004; 9: 255–63
   PubMedGoogle Scholar
• Robson SC, Simpson H, Ball E, Lyall F, Bulmer JN. Punch biopsy of the human placental bed. Am J Obstet Gynecol. 2002; 187: 1349–55
   PubMed Web of Science ®Google Scholar
• Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD. Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. BJOG. 2006; 113: 580–9
   PubMed Web of Science ®Google Scholar
• Sander CM, Gilliland D, Richardson A, Foley KM, Fredericks J. Stillbirths with placental hemorrhagic endovasculitis: a morphologic assessment with clinical implications. Arch Pathol Lab Med. 2005; 129: 632–8
   PubMed Web of Science ®Google Scholar
• Toal M, Keating S, Machin G, , et al Determinants of adverse perinatal outcome in high-risk women with abnormal uterine artery Doppler. Am J Obstet Gynecol. 2007; In Press.
   PubMed Web of Science ®Google Scholar
• Dekker G. Prothrombotic mechanisms in preeclampsia. Thromb Res. 2005; 115(Suppl 1)17–21
   PubMed Web of Science ®Google Scholar
• Dekker G, Robillard P. Preeclampsia: a couple's disease with maternal and fetal manifestations. Curr Pharm Des. 2005; 11: 699–710
   PubMed Web of Science ®Google Scholar
• Dekker G, Sibai B. Primary, secondary, and tertiary prevention of pre-eclampsia. Lancet. 2001; 357(9251)209–15
   PubMed Web of Science ®Google Scholar
• Ferrazzi E, Bulfamante G, Mezzopane R, Barbera A, Ghidini A, Pardi G. Uterine Doppler velocimetry and placental hypoxic ischemic lesion in pregnancies with fetal intrauterine growth restriction. Placenta. 1999; 20: 389–94
   PubMed Web of Science ®Google Scholar
• Viero S, Chaddha V, Alkazaleh F, et al. Prognostic value of placental ultrasound in pregnancies complicated by absent end-diastolic flow velocity in the umbilical arteries. Placenta. 2004; 25: 735–41
   PubMed Web of Science ®Google Scholar
• Weisberg L, Kingdom J, Keating S, et al. Treatment options in fetomaternal hemorrhage: four case studies. J Obstet Gynaecol Can. 2004; 26: 893–8
   PubMedGoogle Scholar
• Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999; 354(9193)1896–900
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000; 283: 2008–12
   PubMed Web of Science ®Google Scholar
• Berg D, Meltzer V. Outpatient management of placental insufficiency with heparin. J Perinat Med. 1978; 6: 141–8
   PubMed Web of Science ®Google Scholar
• Buyse FGC, Wormgoor BH, Bernard JT, Koudstaal J. Anticoagulant therapy of patients with repeated placental infarction. Obstet Gynecol. 1974; 43: 844–8
   PubMed Web of Science ®Google Scholar
• Bonnar J, Redman CWG, Sheppard BL. Treatment of fetal growth retardation in utero with heparin and dipyridamole. Eur J Obstet Gynecol Reprod Biol. 1975; 5: 123–34
   PubMedGoogle Scholar
• Fuke Y, Aono T, Imai S, Suehara N, Fujita T, Nakayama M. Clinical significance and treatment of massive intervillous fibrin deposition associated with recurrent fetal growth retardation. Gynecol Obstet Invest. 1994; 38: 5–9
   PubMed Web of Science ®Google Scholar
• Moe N. Anticoagulant therapy in the prevention of placental infarction and perinatal death. Obstet Gynecol. 1982; 59: 481–3
   PubMed Web of Science ®Google Scholar
• Alkazaleh F, Viero S, Simchen M, et al. Ultrasound diagnosis of severe thrombotic placental damage in the second trimester: an observational study. Ultrasound Obstet Gynecol. 2004; 23: 472–6
   PubMed Web of Science ®Google Scholar
• Chupin L, Herrmann JM, Maillet R, et al. The effects of heparin in underdevelopment of the fetus due to maternal vascular conditions. J Gynecol Obstet Biol Reprod. 1978; 7: 849–54
   PubMedGoogle Scholar
• Yu Y, Shen L, Zhong M, et al. Effect of heparin on fetal growth restriction. Chin J Obstet Gynecol. 2004; 39: 793–6
   Google Scholar
• Dugoff L, Hobbins JC, Malone FD, et al. Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol. 2005; 106: 260–7
   PubMed Web of Science ®Google Scholar
• Smith GC, Shah I, Crossley JA, et al. Pregnancy-associated plasma protein A and alphafetoprotein and prediction of adverse perinatal outcome. Obstet Gynecol. 2006; 107: 161–6
   PubMed Web of Science ®Google Scholar
• Albaiges G, Missfelder-Lobos H, Lees C, Parra M, Nicolaides KH. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks’ gestation. Obstet Gynecol. 2000; 96: 559–64
   PubMed Web of Science ®Google Scholar
• Reister F, Frank HG, Kingdom J, et al. Macrophage induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preecplamptic women. Lab Invest. 2001; 81: 1143–52
   PubMed Web of Science ®Google Scholar
• Yu CK, Smith GC, Papageorghiou AT, Cacho AM, Nicolaides KH. An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. Am J Obstet Gynecol. 2005; 193: 429–36
   PubMed Web of Science ®Google Scholar
• Coleman MA, McCowan LM, North RA. Mid-trimester uterine artery Doppler screening as a predictor of adverse pregnancy outcome in high-risk women. Ultrasound Obstet Gynecol. 2000; 15: 7–12
   PubMed Web of Science ®Google Scholar
• Hershkovitz R, de Swiet M, Kingdom J. Mid-trimester placentation assessment in high-risk pregnancies using maternal serum screening and uterine artery Doppler. Hypertens Pregnancy. 2005; 24: 273–80
   PubMed Web of Science ®Google Scholar
• Harrington K, Fayyad A, Thakur V, Aquilina J. The value of uterine artery Doppler in the prediction of uteroplacental complications in multiparous women. Ultrasound Obstet Gynecol. 2004; 23: 50–5
   PubMed Web of Science ®Google Scholar
• Schwarze A, Nelles I, Krapp M, et al. Doppler ultrasound of the uterine artery in the prediction of severe complications during low-risk pregnancies. Arch Gynecol Obstet. 2005; 271: 46–52
   PubMedGoogle Scholar
• Whittle W, Chaddha V, Wyatt P, Huppertz B, Kingdom J. Ultrasound detection of placental insufficiency in women with ‘unexplained’ abnormal maternal serum screening results. Clin Genet. 2006; 69: 97–104
   PubMed Web of Science ®Google Scholar
• Alkazaleh F, Chaddha V, Viero S, et al. Second trimester prediction of severe placental complications in women with combined elevations in alpha-fetoprotein and human chorionic gonadotropin. Am J Obstet Gynecol. 2006; 194: 821–7
   PubMed Web of Science ®Google Scholar
• Jauniaux E, Avni FE, Elkhazen N, Wilkin P, Hustin J. Morphologic study of ultrasonic placental anomalies in the second half of pregnancy. J Gynecol Obstet Biol Reprod. 1989; 18: 601–13
   PubMedGoogle Scholar
• Dombrowski MP, Wolfe HM, Saleh A, Evans MI, O'Brien J. The sonographically thick placenta: a predictor of increased perinatal morbidity and mortality. Ultrasound Obstet Gynecol. 1992; 2: 252–5
   PubMed Web of Science ®Google Scholar
• Elchalol U, Ezra Y, Levi Y, et al. Sonographically thick placenta: a marker for increased perinatal risk-a prospective cross-sectional study. Placenta. 2000; 21: 268–72
   PubMed Web of Science ®Google Scholar
• Williams MA, Hickok DE, Zingheim RW. Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes. Am J Obstet Gynecol. 1992; 167: 1032–7
   PubMed Web of Science ®Google Scholar
• Chaddha V, Viero S, Huppertz B, Kingdom J. Developmental biology of the placenta and the origins of placental insufficiency. Semin Fetal Neonatal Med. 2004; 9: 357–69
   PubMedGoogle Scholar
• Toal M, Chan C, Fallah S, et al. Utility of a placental profile in high-risk pregnancies. Am J Obstet Gynecol. 2007; 196: 363el7
   Web of Science ®Google Scholar
• Audibert F, Benchimol Y, Benattar C, Champagne C, Frydman R. Prediction of pre-eclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry. Fetal Diagn Ther. 2005; 20: 48–53
   PubMed Web of Science ®Google Scholar
• Smith GC, Shah I, White IR, Pell JP, Crossley JA, Dobbie R. Maternal and biochemical predictors of antepartum stillbirth among nulliparous women in relation to gestational age of fetal death. BJOG. 2007; 114: 705–14
   PubMed Web of Science ®Google Scholar
• Kadyrov M, Kingdom J, Huppertz B. Divergent trophoblast invasion and apoptosis in placental bed spiral arteries from pregnancies complicated by maternal anemia and early-onset pre-eclampsia/intrauterine growth restriction. Am J Obstet Gynecol. 2006; 194: 557–63
   PubMed Web of Science ®Google Scholar
• Bose P, Black S, Kadyrov M, et al. Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure. Am J Obstet Gynecol. 2005; 192: 23–30
   PubMed Web of Science ®Google Scholar
• Cross JC. Placental function in development and disease. Reprod Fertil Dev. 2006; 18: 71–6
   PubMed Web of Science ®Google Scholar
• Macara L, Kingdom JPC, Kaufmann P, et al. Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical artery Doppler waveforms. Placenta. 1996; 17: 37–48
   PubMed Web of Science ®Google Scholar
• Sood R, Kalloway S, Mast AE, Hillard CJ, Weiler H. Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells. Blood. 2006; 107: 3173–80
   PubMed Web of Science ®Google Scholar
• Greer IA. Anticoagulants in pregnancy. J Thromb Thrombolysis. 2006; 21: 57–65
   PubMed Web of Science ®Google Scholar
• www.controlled-trials.com/ISRCTN88675588/.
   Google Scholar